Genomes: Let’s Make Rare Disease Rare

Over 30,000,000 people in the US have a rare or undiagnosed disease. With no answer, these patients embark on a diagnostic odyssey– multiple specialists and diagnostic tests, ineffective (sometimes harmful) medications and therapeutic intervention. Whole genome sequencing is the driving force behind the precision medicine revolution-- providing a diagnosis to more and more patients while creating the foundational for a fundamental shift in healthcare from reactive to predictive.

[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]